source
- Merck KGaA's US research site to cut 20 jobs amid broader R&D downsizingMerck KGaA's North American division, EMD Serono, announced it will lay off 20 employees at its Billerica, Massachusetts research site. The cuts are slated to take effect in the second half of Oct…
- Evaxion drops solid tumor vaccine program to prioritize brain cancer vaccine candidateEvaxion Biotech announced it has discontinued development of its next‑generation solid tumor vaccine, EVX‑03, and will redirect resources toward a brain cancer vaccine candidate developed with Duke…